Related references
Note: Only part of the references are listed.The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics
A. Blank et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Hepatic Uptake of Conjugated Bile Acids Is Mediated by Both Sodium Taurocholate Cotransporting Polypeptide and Organic Anion Transporting Polypeptides and Modulated by Intestinal Sensing of Plasma Bile Acid Levels in Mice
Davor Slijepcevic et al.
HEPATOLOGY (2017)
New Therapeutic Concepts in Bile Acid Transport and Signaling for Management of Cholestasis
Michael Trauner et al.
HEPATOLOGY (2017)
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study
Vinod S. Hegade et al.
LANCET (2017)
Current and future therapies for inherited cholestatic liver diseases
Wendy L. van der Woerd et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response
Shi-Ying Cai et al.
JCI INSIGHT (2017)
Pharmacological Inhibition of Apical Sodium-Dependent Bile Acid Transporter Changes Bile Composition and Blocks Progression of Sclerosing Cholangitis in Multidrug Resistance 2 Knockout Mice
Alexander G. Miethke et al.
HEPATOLOGY (2016)
Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis
Anna Baghdasaryan et al.
JOURNAL OF HEPATOLOGY (2016)
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
Antje Blank et al.
JOURNAL OF HEPATOLOGY (2016)
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
Pavel Bogomolov et al.
JOURNAL OF HEPATOLOGY (2016)
Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na+-taurocholate cotransporting polypeptide knockout mice
Davor Slijepcevic et al.
HEPATOLOGY (2015)
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2015)
Sodium Taurocholate Cotransporting Polypeptide (SLC10A1) Deficiency: Conjugated Hypercholanemia Without a Clear Clinical Phenotype
Frederic M. Vaz et al.
HEPATOLOGY (2015)
The Receptor TGR5 Protects the Liver From Bile Acid Overload During Liver Regeneration in Mice
Noemie Pean et al.
HEPATOLOGY (2013)
Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study
Jocelyn Trottier et al.
DIGESTIVE AND LIVER DISEASE (2012)
A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes
Simon Hohenester et al.
HEPATOLOGY (2012)
Novel insight into mechanisms of cholestatic liver injury
Benjamin L. Woolbright et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Bile Acids Induce Inflammatory Genes in Hepatocytes A Novel Mechanism of Inflammation during Obstructive Cholestasis
Katryn Allen et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The G-Protein-Coupled Bile Acid Receptor, Gpbar1 (TGR5), Negatively Regulates Hepatic Inflammatory Response Through Antagonizing Nuclear Factor Kappa Light-Chain Enhancer of Activated B Cells (NF-κB) in Mice
Yan-Dong Wang et al.
HEPATOLOGY (2011)
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
Curtis D. Klaassen et al.
PHARMACOLOGICAL REVIEWS (2010)
Nuclear Receptor Regulation of the Adaptive Response of Bile Acid Transporters in Cholestasis
Martin Wagner et al.
SEMINARS IN LIVER DISEASE (2010)
Expression and function of the bile acid receptor TGR5 in Kupffer cells
Verena Keitel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis
Angela L. Slitt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration
WD Huang et al.
SCIENCE (2006)
Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis
P Hruz et al.
GUT (2006)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion
L Pawlikowska et al.
HUMAN MOLECULAR GENETICS (2004)
Spontaneous cholecysto- and hepatolithiasis in Mdr2(-/-) mice: A model for low phospholipid-associated cholelithiasis
F Lammert et al.
HEPATOLOGY (2004)
Bile acid-induced Mallory body formation in drug-primed mouse liver
P Fickert et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles
P Fickert et al.
GASTROENTEROLOGY (2002)
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
B Goodwin et al.
MOLECULAR CELL (2000)
Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant
JM Saito et al.
GASTROENTEROLOGY (2000)
Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors
TT Lu et al.
MOLECULAR CELL (2000)
Share Paper
